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DEAR EDITOR, The dramatic presentation of a collodion baby is
most commonly associated with a diagnosis of autosomal
recessive ichthyosis (ARCI). We investigated a family wherein
the father and all four children were collodion at birth, imply-
ing an autosomal dominant inheritance pattern. Postnatally,
the affected individuals presented with variable degrees of
generalized ichthyosis and palmoplantar keratoderma (PPK)
(Fig. 1). These clinical features were more pronounced in the
father than in the children, and were reported to have become
more prominent with age. The phenotype was of generalized
nonerythematous xerosis and fine scaling, with adherent larger
scale on the lower legs, and mild PPK that exhibited honey-
comb patterning. The mother was unaffected and the parents
were nonconsanguineous. One of the children also had mod-
erate neurodevelopmental delay and microcephaly, and the
father had asthma.
With research ethics committee approval, blood was taken
from one child and both parents, and DNA was extracted
using standard methods. Skin scrapings were obtained from
the father and the child, with a 4-mm punch skin biopsy
taken from the father. Next-generation sequencing of leuco-
cyte DNA was performed using a Nextera Custom Enrich-
ment Kit (Illumina, San Diego, CA, U.S.A.) targeting exonic
regions of clinically relevant published dermatology genes,
including known ichthyosis and PPK genes (Table S1; see
Supporting Information). A 50-ng DNA sample was simulta-
neously fragmented using Illumina Enrichment Sample Prep
and tagged with adaptors. Polymerase chain reaction (PCR)
introduced sample-specific indexes to the library, and fol-
lowing quantification this was hybridized to the custom-
capture probes. Streptavidin beads captured the probes con-
taining the targeted regions of interest and a series of
washes removed nonspecific binding from the beads. This
enrichment and capture was repeated once to enrich the
target regions further. The enriched library was amplified
by limited rounds of PCR, quantified, diluted and sequenced
on the Illumina MiSeq. Analysis was using an in-house
pipeline, where FASTQ files were aligned using Burrows–
Wheeler Aligner1 and indexed with SAMtools (http://sam-
tools.sourceforge.net/).2 Variant calling was performed with
VarScan (http://varscan.sourceforge.net/),3,4 and VCF files
were annotated with Variant Effect Predictor (http://www.
ensembl.org). Annotated variants were then filtered in
Microsoft Excel, BAM files reviewed manually and mutations
confirmed using Sanger sequencing.
A novel heterozygous deletion inducing a frameshift was
found in the loricrin gene Chr1 (GRCh37): g.153234085_
153234086del, LOR c.660_661delGC, p.Gln222Alafs*113,
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Fig 1. (a) Transgradient palmar keratoderma, (b) honeycomb
patterning on the palm and (c) sole, (d) ichthyosis on the lower leg,
(e) microdeletion in LOR shown by next-generation sequencing and
(f) confirmed by Sanger sequencing.
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predicted in silico as possibly damaging (Polyphen score 0.799;
http://genetics.bwh.harvard.edu/pph2/) (Fig. 1). This estab-
lished a diagnosis of loricrin keratoderma (previously known
as Vohwinkel syndrome with ichthyosis, or Vohwinkel syn-
drome variant), distinct from classical Vohwinkel syndrome
by the co-occurrence of generalized ichthyosis and the absence
of hearing loss.5 The two conditions are genotypically distinct,
with Vohwinkel syndrome due to mutations in GJB2 and Voh-
winkel with ichthyosis due to mutations in LOR.6 The occur-
rence of constrictive digital bands leading to autoamputation
is variably reported to be a feature of the variant form, but
was not present in this family.
Comparison of this novel mutation with previously
described pathogenic mutations in this form of loricrin kerato-
derma revealed a common mechanism of frameshift indels
affecting the C terminus of the protein,7 with this being the
first deletion reported in the literature. To characterize this
mutation further we performed Western blotting for loricrin
monomers and dimers on skin scale and whole-skin lysate,
and immunofluorescence for loricrin, interleukin (IL)-1a, ker-
atin 1 and mouse double minute 2 homologue (MDM2) on
whole skin (Data S1; see Supporting Information). Monomeric
and dimeric loricrin were clearly detectable in the patient’s
skin lysate compared with the normal skin lysate, where only
the monomeric form was detected, There was weak expres-
sion of dimer in patient skin scale, compared with no free
loricrin detectable in control scale (Fig. 2a). This defective
incorporation of loricrin into the cornified envelope is analo-
gous to that seen in ARCI.8 The domain of loricrin expression
was expanded in patient hyperkeratotic skin, with nucleolar
expression of loricrin as previously reported with insertions
(Fig. 2b).7 Histological analysis of patient skin showed not
only hyperkeratosis, but also focal areas of parakeratosis
(Fig. 2c)
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Fig 2. Western blots (WB) and immunofluorescence of the proband reveal features common to both loricrin keratoderma and autosomal recessive
ichthyosis (ARCI). (a) Western blot of whole-cell lysates and scale from the proband and an unaffected control. Note the monomeric and dimeric
loricrin in the proband skin lysate. No free loricrin is detectable in the control scale, while weak expression of loricrin dimer is detected in the
proband scale. These data specifically indicate the change in expression of wild-type loricrin as a result of the presence of the mutant loricrin. (b)
Immunofluorescence of loricrin in the proband and control skin. The domain of loricrin expression is expanded in proband skin. (c) Histology
and immunofluorescence of interleukin (IL)-1A, keratin 1 and mouse double minute 2 homologue (MDM2) in control skin, proband skin and
representative samples of ARCI skin.9 Focal parakeratosis is indicated in the proband skin. Expression of both IL-1A and MDM2 is increased in the
spinous and basal layers of both proband and ARCI skin, while keratin 1 increase is seen only in the ARCI skin. Bar 50 lm (b, both top and
bottom panels, and c).
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The upregulation of IL-1a and MDM2 occurs in all lamel-
lar-type ARCIs irrespective of genotype,9 and is consistent
with the hyperkeratosis observed in MDM2-overexpressing
mice.10 The upregulation of these proteins in patient skin pro-
vides further support for a common mechanism for hyperker-
atosis.8,9 Interestingly keratin 1 expression was not increased
in affected skin, further refining the hyperkeratosis signature
common to ichthyoses due to different genetic defects.
These results describe a novel mutation and the first dele-
tion leading to loricrin keratoderma unusually presenting with
collodion membrane, described only once previously,11 and
provide further evidence of a common, MDM2-mediated gene
expression pathway leading to ichthyosis and collodion mem-
brane formation. This diagnosis should be considered as a rare
cause of the clinical presentation of collodion baby.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article at the publisher’s website:
Data S1. Supplementary methods.
Table S1. Ichthyosis and palmoplantar keratoderma genes
covered by the custom-designed next-generation sequencing
panel at the time of investigation.
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